Tower Research Capital (TRC)’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-496
| Closed | -$8.24K | – | 5719 |
|
|
2024
Q1 | $8.24K | Buy |
+496
| New | +$8.24K | ﹤0.01% | 4056 |
|
|
2021
Q4 | – | Sell |
-16
| Closed | – | – | 6178 |
|
|
2021
Q3 | $0 | Buy |
+16
| New | – | ﹤0.01% | 5803 |
|
|
2020
Q4 | – | Sell |
-35
| Closed | -$1K | – | 5146 |
|
|
2020
Q3 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 4682 |
|
|
2020
Q2 | – | Sell |
-519
| Closed | -$10K | – | 4760 |
|
|
2020
Q1 | $10K | Buy |
+519
| New | +$10K | ﹤0.01% | 2012 |
|
|
2019
Q4 | – | Sell |
-134
| Closed | -$3K | – | 3636 |
|
|
2019
Q3 | $3K | Buy |
134
+47
| +54% | +$1.05K | ﹤0.01% | 3530 |
|
|
2019
Q2 | $2K | Buy |
+87
| New | +$2K | ﹤0.01% | 3245 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$2K | – | 3841 |
|
|
2018
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 3323 |
|
|
2016
Q3 | – | Sell |
-36
| Closed | -$1K | – | 3723 |
|
|
2016
Q2 | $1K | Sell |
36
-24
| -40% | -$667 | ﹤0.01% | 4131 |
|
|
2016
Q1 | $1K | Sell |
60
-40
| -40% | -$667 | ﹤0.01% | 3655 |
|
|
2015
Q4 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 3405 |
|